Assets, Current of Alzamend Neuro, Inc. from 30 Apr 2020 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Alzamend Neuro, Inc. quarterly Assets, Current in USD history and change rate from 30 Apr 2020 to 31 Oct 2025.
  • Alzamend Neuro, Inc. Assets, Current for the quarter ending 31 Oct 2025 was $4,721,448, a 0.95% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Change (%)

Alzamend Neuro, Inc. Quarterly Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,721,448 -$45,294 -0.95% 31 Oct 2025 10-Q 09 Dec 2025 2026 Q2
Q2 2025 $5,928,830 +$4,512,639 +319% 31 Jul 2025 10-Q 10 Sep 2025 2026 Q1
Q1 2025 $4,177,377 +$3,722,135 +818% 30 Apr 2025 10-Q 09 Dec 2025 2026 Q2
Q4 2024 $3,947,343 +$3,353,738 +565% 31 Jan 2025 10-Q 10 Mar 2025 2024 Q3
Q3 2024 $4,766,742 +$3,984,861 +510% 31 Oct 2024 10-Q 11 Dec 2024 2024 Q2
Q2 2024 $1,416,191 -$997,413 -41% 31 Jul 2024 10-Q 11 Sep 2024 2024 Q1
Q1 2024 $455,242 -$5,380,540 -92% 30 Apr 2024 10-K 22 Jul 2025 2025 FY
Q4 2023 $593,605 -$7,823,207 -93% 31 Jan 2024 10-Q 25 Mar 2024 2024 Q3
Q3 2023 $781,881 -$9,552,506 -92% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q2
Q2 2023 $2,413,604 -$9,701,059 -80% 31 Jul 2023 10-Q 13 Sep 2023 2024 Q1
Q1 2023 $5,835,782 -$8,577,752 -60% 30 Apr 2023 10-K 30 Jul 2024 2024 FY
Q4 2022 $8,416,812 -$4,012,304 -32% 31 Jan 2023 10-Q 15 Mar 2023 2023 Q3
Q3 2022 $10,334,387 -$4,166,509 -29% 31 Oct 2022 10-Q 12 Dec 2022 2022 Q2
Q2 2022 $12,114,663 -$4,702,988 -28% 31 Jul 2022 10-Q 13 Sep 2022 2022 Q1
Q1 2022 $14,413,534 +$11,500,944 +395% 30 Apr 2022 10-K 27 Jul 2023 2023 FY
Q4 2021 $12,429,116 31 Jan 2022 10-Q 15 Mar 2022 2022 Q3
Q3 2021 $14,500,896 31 Oct 2021 10-Q 13 Dec 2021 2022 Q2
Q2 2021 $16,817,651 31 Jul 2021 10-Q 13 Sep 2021 2022 Q1
Q1 2021 $2,912,590 +$1,098,575 +61% 30 Apr 2021 10-K 19 Jul 2022 2022 FY
Q1 2020 $1,814,015 30 Apr 2020 10-K 29 Jul 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.